LAC Med Berhad (KLSE:LACMED)

LAC Med Berhad Statistics

Total Valuation

LAC Med Berhad has a market cap or net worth of MYR 314.00 million. The enterprise value is 273.83 million.

Market Cap	314.00M
Enterprise Value	273.83M

Important Dates

The next estimated earnings date is Friday, June 5, 2026.

Earnings Date	Jun 5, 2026
Ex-Dividend Date	n/a

Share Statistics

LAC Med Berhad has 400.00 million shares outstanding. The number of shares has increased by 5,726.58% in one year.

Current Share Class	400.00M
Shares Outstanding	400.00M
Shares Change (YoY)	+5,726.58%
Shares Change (QoQ)	+11,395.07%
Owned by Insiders (%)	73.56%
Owned by Institutions (%)	5.37%
Float	105.75M

Valuation Ratios

The trailing PE ratio is 9.39.

PE Ratio	9.39
Forward PE	n/a
PS Ratio	1.71
PB Ratio	2.62
P/TBV Ratio	2.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.17, with an EV/FCF ratio of -10.06.

EV / Earnings	15.23
EV / Sales	1.49
EV / EBITDA	10.17
EV / EBIT	10.96
EV / FCF	-10.06

Financial Position

The company has a current ratio of 2.19, with a Debt / Equity ratio of 0.26.

Current Ratio	2.19
Quick Ratio	1.87
Debt / Equity	0.26
Debt / EBITDA	1.14
Debt / FCF	-1.13
Interest Coverage	21.36

Financial Efficiency

Return on equity (ROE) is 20.75% and return on invested capital (ROIC) is 44.26%.

Return on Equity (ROE)	20.75%
Return on Assets (ROA)	9.37%
Return on Invested Capital (ROIC)	44.26%
Return on Capital Employed (ROCE)	20.04%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.84M
Profits Per Employee	179,792
Employee Count	100
Asset Turnover	1.10
Inventory Turnover	5.19

Taxes

In the past 12 months, LAC Med Berhad has paid 7.64 million in taxes.

Income Tax	7.64M
Effective Tax Rate	29.89%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	0.85
200-Day Moving Average	n/a
Relative Strength Index (RSI)	42.10
Average Volume (20 Days)	921,375

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LAC Med Berhad had revenue of MYR 183.55 million and earned 17.98 million in profits. Earnings per share was 0.08.

Revenue	183.55M
Gross Profit	51.73M
Operating Income	24.98M
Pretax Income	25.55M
Net Income	17.98M
EBITDA	26.75M
EBIT	24.98M
Earnings Per Share (EPS)	0.08

Balance Sheet

The company has 70.83 million in cash and 30.62 million in debt, with a net cash position of 40.21 million or 0.10 per share.

Cash & Cash Equivalents	70.83M
Total Debt	30.62M
Net Cash	40.21M
Net Cash Per Share	0.10
Equity (Book Value)	119.90M
Book Value Per Share	0.30
Working Capital	107.48M

Cash Flow

In the last 12 months, operating cash flow was -15.73 million and capital expenditures -11.48 million, giving a free cash flow of -27.22 million.

Operating Cash Flow	-15.73M
Capital Expenditures	-11.48M
Depreciation & Amortization	1.14M
Net Borrowing	6.80M
Free Cash Flow	-27.22M
FCF Per Share	-0.07

Margins

Gross margin is 28.19%, with operating and profit margins of 13.61% and 9.80%.

Gross Margin	28.19%
Operating Margin	13.61%
Pretax Margin	13.92%
Profit Margin	9.80%
EBITDA Margin	14.57%
EBIT Margin	13.61%
FCF Margin	n/a

Dividends & Yields

LAC Med Berhad does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	27.81%
Buyback Yield	-5,726.58%
Shareholder Yield	-5,726.58%
Earnings Yield	5.73%
FCF Yield	-8.67%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5